Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology

Mancinelli CR, De Rossi N, Capra R

Therapeutics and Clinical Risk Management 2021, 17:765-776

Published Date: 30 July 2021